These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31232202)

  • 1. Value-Based Insurance Design: Current Evidence and Future Directions.
    Yeung K
    J Manag Care Spec Pharm; 2019 Jul; 25(7):738-741. PubMed ID: 31232202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are the Benefits of Value-Based Insurance Design Conclusive?
    Farley JF
    J Manag Care Spec Pharm; 2019 Jul; 25(7):736-738. PubMed ID: 31232204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Employer and Plan Sponsor Views on Pharmacy Reimbursement.
    Stull M; Gupton C
    J Manag Care Spec Pharm; 2020 Jun; 26(6):710-712. PubMed ID: 32463776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to make value-based health insurance designs more effective? A systematic review and meta-analysis.
    Krack G
    Eur J Health Econ; 2019 Aug; 20(6):841-856. PubMed ID: 30923986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consumers' Perceptions And Choices Related To Three Value-Based Insurance Design Approaches.
    Perez SL; Gosdin M; Pintor JK; Romano PS
    Health Aff (Millwood); 2019 Mar; 38(3):456-463. PubMed ID: 30830829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can broader diffusion of value-based insurance design increase benefits from US health care without increasing costs? Evidence from a computer simulation model.
    Braithwaite RS; Omokaro C; Justice AC; Nucifora K; Roberts MS
    PLoS Med; 2010 Feb; 7(2):e1000234. PubMed ID: 20169114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value-based insurance design: embracing value over cost alone.
    Fendrick AM; Chernew ME; Levi GW
    Am J Manag Care; 2009 Dec; 15(10 Suppl):S277-83. PubMed ID: 20088631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a large regional health plan's value-based insurance design program on statin use.
    Frank MB; Fendrick AM; He Y; Zbrozek A; Holtz N; Leung S; Chernew ME
    Med Care; 2012 Nov; 50(11):934-9. PubMed ID: 23047782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value-based health insurance design: how much does socioeconomic status matter?
    Sherman BW; Addy C
    Am J Manag Care; 2018 Jul; 24(7):318-321. PubMed ID: 30020750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of increased cost-sharing on low-value service use.
    Gruber J; Maclean JC; Wright B; Wilkinson E; Volpp KG
    Health Econ; 2020 Oct; 29(10):1180-1201. PubMed ID: 32686138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value-based insurance design: barriers to implementation in radiology.
    Kelly AM; Cronin P
    Acad Radiol; 2011 Sep; 18(9):1115-22. PubMed ID: 21680205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Employer-sponsored health insurance: down but not out.
    Christanson JB; Tu HT; Samuel DR
    Issue Brief Cent Stud Health Syst Change; 2011 Oct; (137):1-5. PubMed ID: 22034676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value-based insurance design yields near- and long-term improvements in medication adherence.
    Collado M
    Find Brief; 2013 Mar; 16(1):1-3. PubMed ID: 23539769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to value-based insurance design.
    Kelly AM; Cronin P; Carlos RC
    J Am Coll Radiol; 2008 Nov; 5(11):1118-24. PubMed ID: 18954811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs.
    Buttorff C; Andersen MS; Riggs KR; Alexander GC
    Health Aff (Millwood); 2015 Mar; 34(3):467-76. PubMed ID: 25732498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ACA’s Cost-Sharing Reduction Plans: A Key to Affordable Health Coverage for Millions of U.S. Workers.
    Gabel J; Whitmore H; Green M; Call A; Stromberg S; Oran R
    Issue Brief (Commonw Fund); 2016 Oct; 35():1-12. PubMed ID: 27827407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spiro Writing Awards 2016.
    Norman K; Hayward H
    Conn Med; 2016; 80(6):365-7. PubMed ID: 27509645
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory, Policy, and Operational Considerations for Outcomes-Based Risk-Sharing Agreements in the U.S. Market: Opportunities for Reform.
    Goodman C; Villarivera C; Gregor K; van Bavel J
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1174-1181. PubMed ID: 31535596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value-based insurance design: benefits beyond cost and utilization.
    Gibson TB; Maclean RJ; Chernew ME; Fendrick AM; Baigel C
    Am J Manag Care; 2015 Jan; 21(1):32-5. PubMed ID: 25880148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.